Alterity Therapeutics Executes Conversion of 40,209 Options into Ordinary Shares at AUD 0.50 Each
Alterity Therapeutics Limited (ATH) has applied for quotation of 40,209 ordinary fully paid shares following the exercise of options expiring 31 August 2026. The shares were issued on 21 July 2026 at an exercise price of AUD 0.50 per security. The conversion brings Alterity's total quoted ordinary share capital to 217,629,367 shares, while the company maintains a substantial portfolio of unquoted options across multiple exercise prices and expiry dates.
- July 21, 2026 01:02 PM AEST
- Anjali Anand
Audinate Group Limited to Announce FY26 Financial Results on 17 August 2026 with Live Zoom Webinar for Investors
Audinate Group Limited (ASX: AD8), the developer of the professional audio-visual industry-leading Dante® media networking solution, announced it will release its FY26 financial results on 17 August 2026. The company will host a live webinar via Zoom the same day at 9.30am (AEST) to discuss the results, providing investors and stakeholders an opportunity to hear directly from management about the company's performance and strategy moving forward.
- July 21, 2026 01:01 PM AEST
- Aditi Sarkar
Recce Pharmaceuticals Secures FDA QIDP Status and Expands Phase 3 Trial for RECCE® 327 Gel, Advancing Commercial Launch Plans
Recce Pharmaceuticals Ltd (ASX: RCE) has announced significant regulatory, clinical and commercial progress for its lead anti-infective asset RECCE® 327, a gel treatment for diabetic foot infections. The company's Phase 3 clinical trial in Indonesia has expanded patient eligibility to include moderate diabetic foot infections, while the U.S. Food and Drug Administration granted Qualified Infectious Disease Product (QIDP) designation providing 10 years of market exclusivity and fast-track approval pathways. Recce has also signed a non-binding term sheet with a leading Middle Eastern pharmaceutical company for a proposed 10-year exclusive multi-country licensing agreement, marking a significant commercialisation milestone ahead of expected interim trial data in Q3 2026.
- July 21, 2026 12:55 PM AEST
- Aakashdeep
Terrain Minerals Progresses Toward Maiden Resource Estimate at Lightning Gold Deposit
Terrain Minerals Limited (ASX: TMX) has completed significant exploration work during the June 2026 quarter across its flagship Smokebush Project in Western Australia, with a maiden Mineral Resource Estimate for the Lightning gold deposit due in July 2026. The company reported 46 drill holes totalling 8,256 metres of RC and diamond drilling at Smokebush, alongside progress on rare earth and lithium exploration at other projects, following a $1.5 million capital raise in May 2026.
- July 21, 2026 12:55 PM AEST
- Aditi Sarkar
FMR Resources Plans 150,000 Share Issuance as Deferred Payment for Los Warbos Mining Concession Acquisition
FMR Resources Limited has announced a proposed issue of 150,000 ordinary fully paid shares as deferred performance consideration linked to the acquisition of the Los Warbos Project mining concessions. The share issuance is conditional upon the company announcing a Mineral Resource Estimate in accordance with the JORC Code 2012 within five years of exercising its option agreement. Shareholders are scheduled to vote on the proposal in October 2031, with shares expected to be issued in December 2031 if approved.
- July 21, 2026 12:55 PM AEST
- Aditi Sarkar
Plato Global Alpha Fund Complex ETF Posts 4.83% Return in June 2026, Surpasses MSCI World Benchmark by 1.72%
Pinnacle Fund Services Limited, the responsible entity for the Plato Global Alpha Fund Complex ETF (ASX:PGA1), has released its monthly investment update for the period ending 30 June 2026. The fund delivered strong performance in June with a 4.83% return, outperforming the MSCI World Net Return Index by 1.72%. Since inception in September 2021, the fund has achieved an annualized return of 24.69% after fees, significantly outperforming its benchmark by 12.27% per annum and maintaining positive relative performance in 93% of rolling quarters.
- July 21, 2026 12:55 PM AEST
- Manish Choudhary
Commonwealth Bank (ASX:CBA): What Is Keeping Bank Valuations in Focus?
Commonwealth Bank remains central to Australia’s banking debate as margins, deposits, mortgage competition, credit quality, digital capability and cost discipline shape assessments of valuation and financial resilience today.
- July 21, 2026 12:49 PM AEST
- Sam
Top Financial Stocks: Is QBE Insurance Group (ASX:QBE) Facing a Reset?
QBE remains in focus as premium momentum, underwriting discipline, catastrophe exposure, claims management and capital strength shape the broader Australian financial-sector conversation during a selective reporting-season environment.
- July 21, 2026 12:49 PM AEST
- Sam
Why Is Plenti (ASX:PLT) Making Lending Growth Matter?
Plenti’s record platform activity is sharpening attention on lending demand, origination quality, funding discipline and whether digital finance growth can support consistent operating progress in a selective market.
- July 21, 2026 12:46 PM AEST
- Sam
Vanguard Australian Shares (ASX:VAS): Why Are ETF Markets Watching Closely?
Vanguard Australian Shares remains in focus as diversified exposure, market breadth, sector balance and straightforward portfolio construction reinforce the importance of broad Australian equity participation during a selective market environment.
- July 21, 2026 12:44 PM AEST
- Sam